|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/37 | (2006.01) |
| A61K 38/37 | (2013.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/04 | (2006.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 7/04 | (2018.01) |
| (11) | Patento numeris | 3666283 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19212900.5 |
| Europos patento paraiškos padavimo data | 2014-03-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-06-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-06-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361800293 P | 2013-03-15 | US | |
| 201361817085 P | 2013-04-29 | US | |
| 201361829884 P | 2013-05-31 | US | |
| 201361839477 P | 2013-06-26 | US | |
| 201361863860 P | 2013-08-08 | US | |
| 201361876927 P | 2013-09-12 | US | |
| 201361879955 P | 2013-09-19 | US | |
| 201361897742 P | 2013-10-30 | US |
| (72) |
MALONEY, Kevin , US
ABDUL-FATTAH, Ahmad , US
GAGE, Daniel , US
|
| (73) |
Bioverativ Therapeutics Inc. ,
225 Second Avenue, Waltham MA 02451,
US
|
| (54) | FACTOR VIII POLYPEPTIDE FORMULATIONS |
| FACTOR VIII POLYPEPTIDE FORMULATIONS |